TY  - GEN 
AU  - Gutiérrez Rojas, Luis
AU  - Sánchez-Alonso, Sergio
AU  - García Dorado, Marta
AU  - López Rengel, Paola M.
PY  - 2022
UR  - https://hdl.handle.net/10481/110415
AB  - Background: Treatment of schizophrenia requires long-term medication to prevent relapse. Treatment nonadherence may increase the risk of relapse, leading to increased hospitalizations and emergency room (ER) visits. Long-acting injectables (LAIs) such...
LA  - eng
PB  - Springer
TI  - Impact of 3-Monthly Long-Acting Injectable Paliperidone Palmitate in Schizophrenia: A Retrospective, Real-World Analysis of Population-Based Health Records in Spain.
DO  - 10.1007/s40263-022-00917-1
ER  -